Clinical Features and Genetic Results of Children With Severe FSS Examined by WES
Patient No. . | Sex . | Age, y . | Patient`s Height (SDS) . | Shorter Parent`s Height (SDS) . | IGF-1 (SDS) . | Stimulated GH, μg/L . | Birth Weight (SDS) . | Birth Length (SDS) . | Additional Phenotypic Features . | Gene . | Mutation Status . | Transcript Variant . | Protein Variant . | Parents Available for Genetic Testing . | Conclusion . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SGA only – 5/8 (62.5%) with P/LP variant | |||||||||||||||
1 | F | 10 | −4.32 | −3.54 | −1.68 | 11.0 | −1.64 | −3.05 | — | COL11A1 | M/n | c.2921C>A | p.Pro974Gln | Yes | Likely pathogenic |
2 | M | 14 | −4.10 | −2.89 | −3.68 | 10.0 | −1.64 | −2.39 | Central hypothyroidism | TRHR | M/M | c.392T>C | p.Ile131Thr | Yes | Likely pathogenic (16) |
3 | M | 12 | −3.49 | −3.00 | −0.26 | 11.5 | −3.01 | −3.87 | — | THRA | M/n | c.455G>A | p.Arg152Gln | Yes | Uncertain significance |
4 | M | 10 | −3.42 | −3.03 | −0.98 | 10.2 | −1.62 | −3.26 | Advanced bone age (+1.9 years) | IHH | M/n | c.857C>T | p.Pro286Leu | No | Uncertain significance |
5 | M | 9 | −3.34 | −2.67 | −0.92 | NA | −2.13 | −3.52 | — | COL9A2 | M/n | c.1834G>A | p.Gly612Arg | Yes | Benign |
6 | M | 16 | −3.06 | −2.75 | 0.16 | 19.3 | −2.39 | −2.57 | Scoliosis | COL11A1 | M/n | c.1543C>G | p.Gln515Glu | Yes | Likely pathogenic |
7 | M | 10 | −2.92 | −3.30 | −0.63 | 29.7 | −1.35 | −2.13 | — | IGF1R | M/n | c.158C>T | p.Thr53Met | Yes | Likely pathogenic |
8 | F | 11 | −2.76 | −2.75 | −1.04 | NA | −2.56 | −4.14 | Frequent OMA, genua valga, advanced bone age (+3.4 y) | COL2A1 | M1/M2 | c.410G>A / c.3106C>G | p.Arg137His/ p.Arg1036Gly | Yes | Likely pathogenic (6) / Likely pathogenic |
GHD only – 4/9 (44.4%) with P/LP variant | |||||||||||||||
9 | M | 14 | −4.95 | −2.89 | −2.48 | 7.22 | −0.94 | −1.78 | Minor stigmata, bilateral cryptorchidism | IGFALS | M/n | c.860C>T | p.Pro287Leu | No | Uncertain significance (17) |
10 | M | 8 | −4.48 | −2.73 | −1.11 | 6.36 | −1.06 | −1.75 | B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulceration | MBTPS2 | M/- | c.1538T>C | p.Leu513Pro | Yes | Likely pathogenic (19) |
PIK3CD | M/n | c.1775T>C | p.Val952Ala | Yes | Uncertain significance | ||||||||||
11 | M | 7 | −4.37 | −2.89 | −1.86 | 9.40 | −0.56 | −1.04 | Limb shortening | FGFR3 | M/n | c.1612A>G | p.Ile538Val | Yes | Likely pathogenic (18) |
12 | F | 8 | −3.50 | −2.60 | −1.57 | 2.50 | 0.04 | −0.95 | Limb shortening | HSPG2 | M/n | c.8044C>T | p.Arg2682Trp | Yes | Benign |
13 | M | 13 | −3.10 | −2.59 | −1.91 | 5.92 | −0.85 | −0.65 | — | PAX6 | M/n | c.13C>G c.392C>G | p.His5Asp p.Ala131Gly | Yes | Benign |
14 | M | 5 | −3.06 | −3.86 | −2.18 | 8.34 | −1.94 | −1.42 | — | HMGA2 | M/n | c.223C>T | p.Arg75Trp | Yes | Likely pathogenic |
15 | M | 9 | −3.04 | −2.75 | −1.82 | 6.06 | −1.57 | −1.68 | Minor stigmata | IGFALS | M/n | c.589C>T | p.Arg197Cys | Yes | Pathogenic |
IHH | M/n | c.1169G>A | p.Arg390His | Yes | Uncertain significance | ||||||||||
16 | M | 8 | −2.75 | −2.75 | −1.23 | 7.79 | −1.02 | −1.35 | — | IGFALS | M/n | c.1195G>A | p.Gly399Arg | No | Uncertain significance |
17 | M | 12 | −2.53 | −2.75 | −1.28 | 8.30 | −1.60 | −0.65 | — | GH1 | M/n | c.478C>T | p.Arg160Trp | Yes | Benign |
FBN1 | M/n | c.902G>T | p.Gly301Val | Yes | Benign | ||||||||||
SGA + GHD – 3/11 (27.3%) with P/LP variant | |||||||||||||||
18 | M | 9 | −4.17 | −3.81 | −1.98 | 5.18 | −1.95 | −3.09 | Hypospadia, minor stigmata | HSPG2 | M/n | c.12874G>A | p.Glu4292Lys | Yes | Benign |
19 | F | 8 | −3.82 | −4.03 | −0.44 | 7.77 | −0.84 | −2.14 | Limb shortening | GLI2 GLI2 | M/n | c.4332G>A c.4333C>T | p.Met1444Ile p.Leu1445Phe | Yes | Benign |
20 | M | 6 | −3.61 | −3.25 | −1.14 | 6.4 | −2.16 | −3.12 | — | — | — | — | — | — | No variant found |
21 | M | 14 | −3.47 | −2.89 | −1.63 | 8.39 | −2.39 | −3.00 | Microcephaly | COL2A1 | M/n | c.3106C>G | p.Arg1036Gly | Yes | Likely pathogenic |
22 | M | 8 | −3.28 | −2.89 | −1.83 | 6.37 | −0.60 | −2.39 | — | — | — | — | — | — | No variant found |
23 | M | 13 | −3.26 | −2.81 | −1.22 | 7.44 | −2.18 | −2.22 | — | SHH | M/n | c.424G>A | p.Glu142Lys | Yes | Benign |
24 | F | 14 | −3.18 | −2.75 | −2.1 | 7.15 | −2.56 | −3.13 | Lower-limb shortening, minor stigmata | GHSR | M/n | c.526G>A | p.Gly176Arg | Yes | Pathogenic |
25 | M | 8 | −2.84 | −2.87 | −0.98 | 5.91 | −2.59 | −2.83 | Minor stigmata | COL10A1 | M/n | c.1581G>C | p.Lys527Asn | Yes | Likely benign |
26 | F | 12 | −2.76 | −2.89 | −3.45 | 3.62 | −2.78 | −1.23 | Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitary | — | — | — | — | — | No variant found |
27 | M | 10 | −2.70 | −2.75 | −0.66 | 3.44 | −2.39 | −3.43 | — | EXT2 | M/n | c.2034G>C | p.Lys678Asn | No | Uncertain significance |
28 | M | 5 | −2.62 | −3.60 | −2.25 | 6.99 | −1.40 | −2.22 | — | FLNB | M/n | c.1601T>G | p.Ile534Ser | Yes | Likely pathogenic |
Patient No. . | Sex . | Age, y . | Patient`s Height (SDS) . | Shorter Parent`s Height (SDS) . | IGF-1 (SDS) . | Stimulated GH, μg/L . | Birth Weight (SDS) . | Birth Length (SDS) . | Additional Phenotypic Features . | Gene . | Mutation Status . | Transcript Variant . | Protein Variant . | Parents Available for Genetic Testing . | Conclusion . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SGA only – 5/8 (62.5%) with P/LP variant | |||||||||||||||
1 | F | 10 | −4.32 | −3.54 | −1.68 | 11.0 | −1.64 | −3.05 | — | COL11A1 | M/n | c.2921C>A | p.Pro974Gln | Yes | Likely pathogenic |
2 | M | 14 | −4.10 | −2.89 | −3.68 | 10.0 | −1.64 | −2.39 | Central hypothyroidism | TRHR | M/M | c.392T>C | p.Ile131Thr | Yes | Likely pathogenic (16) |
3 | M | 12 | −3.49 | −3.00 | −0.26 | 11.5 | −3.01 | −3.87 | — | THRA | M/n | c.455G>A | p.Arg152Gln | Yes | Uncertain significance |
4 | M | 10 | −3.42 | −3.03 | −0.98 | 10.2 | −1.62 | −3.26 | Advanced bone age (+1.9 years) | IHH | M/n | c.857C>T | p.Pro286Leu | No | Uncertain significance |
5 | M | 9 | −3.34 | −2.67 | −0.92 | NA | −2.13 | −3.52 | — | COL9A2 | M/n | c.1834G>A | p.Gly612Arg | Yes | Benign |
6 | M | 16 | −3.06 | −2.75 | 0.16 | 19.3 | −2.39 | −2.57 | Scoliosis | COL11A1 | M/n | c.1543C>G | p.Gln515Glu | Yes | Likely pathogenic |
7 | M | 10 | −2.92 | −3.30 | −0.63 | 29.7 | −1.35 | −2.13 | — | IGF1R | M/n | c.158C>T | p.Thr53Met | Yes | Likely pathogenic |
8 | F | 11 | −2.76 | −2.75 | −1.04 | NA | −2.56 | −4.14 | Frequent OMA, genua valga, advanced bone age (+3.4 y) | COL2A1 | M1/M2 | c.410G>A / c.3106C>G | p.Arg137His/ p.Arg1036Gly | Yes | Likely pathogenic (6) / Likely pathogenic |
GHD only – 4/9 (44.4%) with P/LP variant | |||||||||||||||
9 | M | 14 | −4.95 | −2.89 | −2.48 | 7.22 | −0.94 | −1.78 | Minor stigmata, bilateral cryptorchidism | IGFALS | M/n | c.860C>T | p.Pro287Leu | No | Uncertain significance (17) |
10 | M | 8 | −4.48 | −2.73 | −1.11 | 6.36 | −1.06 | −1.75 | B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulceration | MBTPS2 | M/- | c.1538T>C | p.Leu513Pro | Yes | Likely pathogenic (19) |
PIK3CD | M/n | c.1775T>C | p.Val952Ala | Yes | Uncertain significance | ||||||||||
11 | M | 7 | −4.37 | −2.89 | −1.86 | 9.40 | −0.56 | −1.04 | Limb shortening | FGFR3 | M/n | c.1612A>G | p.Ile538Val | Yes | Likely pathogenic (18) |
12 | F | 8 | −3.50 | −2.60 | −1.57 | 2.50 | 0.04 | −0.95 | Limb shortening | HSPG2 | M/n | c.8044C>T | p.Arg2682Trp | Yes | Benign |
13 | M | 13 | −3.10 | −2.59 | −1.91 | 5.92 | −0.85 | −0.65 | — | PAX6 | M/n | c.13C>G c.392C>G | p.His5Asp p.Ala131Gly | Yes | Benign |
14 | M | 5 | −3.06 | −3.86 | −2.18 | 8.34 | −1.94 | −1.42 | — | HMGA2 | M/n | c.223C>T | p.Arg75Trp | Yes | Likely pathogenic |
15 | M | 9 | −3.04 | −2.75 | −1.82 | 6.06 | −1.57 | −1.68 | Minor stigmata | IGFALS | M/n | c.589C>T | p.Arg197Cys | Yes | Pathogenic |
IHH | M/n | c.1169G>A | p.Arg390His | Yes | Uncertain significance | ||||||||||
16 | M | 8 | −2.75 | −2.75 | −1.23 | 7.79 | −1.02 | −1.35 | — | IGFALS | M/n | c.1195G>A | p.Gly399Arg | No | Uncertain significance |
17 | M | 12 | −2.53 | −2.75 | −1.28 | 8.30 | −1.60 | −0.65 | — | GH1 | M/n | c.478C>T | p.Arg160Trp | Yes | Benign |
FBN1 | M/n | c.902G>T | p.Gly301Val | Yes | Benign | ||||||||||
SGA + GHD – 3/11 (27.3%) with P/LP variant | |||||||||||||||
18 | M | 9 | −4.17 | −3.81 | −1.98 | 5.18 | −1.95 | −3.09 | Hypospadia, minor stigmata | HSPG2 | M/n | c.12874G>A | p.Glu4292Lys | Yes | Benign |
19 | F | 8 | −3.82 | −4.03 | −0.44 | 7.77 | −0.84 | −2.14 | Limb shortening | GLI2 GLI2 | M/n | c.4332G>A c.4333C>T | p.Met1444Ile p.Leu1445Phe | Yes | Benign |
20 | M | 6 | −3.61 | −3.25 | −1.14 | 6.4 | −2.16 | −3.12 | — | — | — | — | — | — | No variant found |
21 | M | 14 | −3.47 | −2.89 | −1.63 | 8.39 | −2.39 | −3.00 | Microcephaly | COL2A1 | M/n | c.3106C>G | p.Arg1036Gly | Yes | Likely pathogenic |
22 | M | 8 | −3.28 | −2.89 | −1.83 | 6.37 | −0.60 | −2.39 | — | — | — | — | — | — | No variant found |
23 | M | 13 | −3.26 | −2.81 | −1.22 | 7.44 | −2.18 | −2.22 | — | SHH | M/n | c.424G>A | p.Glu142Lys | Yes | Benign |
24 | F | 14 | −3.18 | −2.75 | −2.1 | 7.15 | −2.56 | −3.13 | Lower-limb shortening, minor stigmata | GHSR | M/n | c.526G>A | p.Gly176Arg | Yes | Pathogenic |
25 | M | 8 | −2.84 | −2.87 | −0.98 | 5.91 | −2.59 | −2.83 | Minor stigmata | COL10A1 | M/n | c.1581G>C | p.Lys527Asn | Yes | Likely benign |
26 | F | 12 | −2.76 | −2.89 | −3.45 | 3.62 | −2.78 | −1.23 | Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitary | — | — | — | — | — | No variant found |
27 | M | 10 | −2.70 | −2.75 | −0.66 | 3.44 | −2.39 | −3.43 | — | EXT2 | M/n | c.2034G>C | p.Lys678Asn | No | Uncertain significance |
28 | M | 5 | −2.62 | −3.60 | −2.25 | 6.99 | −1.40 | −2.22 | — | FLNB | M/n | c.1601T>G | p.Ile534Ser | Yes | Likely pathogenic |
Abbreviations: F, female; GHD, GH deficiency; LP, likely pathogenic; M, male; M/n, heterozygote; M/M, homozygote; M1/M2, compound heterozygote; M/-, hemizygote; OMA, otitis media acuta; P, pathogenic; SDS, SD score; SGA, small for gestational age.
Clinical Features and Genetic Results of Children With Severe FSS Examined by WES
Patient No. . | Sex . | Age, y . | Patient`s Height (SDS) . | Shorter Parent`s Height (SDS) . | IGF-1 (SDS) . | Stimulated GH, μg/L . | Birth Weight (SDS) . | Birth Length (SDS) . | Additional Phenotypic Features . | Gene . | Mutation Status . | Transcript Variant . | Protein Variant . | Parents Available for Genetic Testing . | Conclusion . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SGA only – 5/8 (62.5%) with P/LP variant | |||||||||||||||
1 | F | 10 | −4.32 | −3.54 | −1.68 | 11.0 | −1.64 | −3.05 | — | COL11A1 | M/n | c.2921C>A | p.Pro974Gln | Yes | Likely pathogenic |
2 | M | 14 | −4.10 | −2.89 | −3.68 | 10.0 | −1.64 | −2.39 | Central hypothyroidism | TRHR | M/M | c.392T>C | p.Ile131Thr | Yes | Likely pathogenic (16) |
3 | M | 12 | −3.49 | −3.00 | −0.26 | 11.5 | −3.01 | −3.87 | — | THRA | M/n | c.455G>A | p.Arg152Gln | Yes | Uncertain significance |
4 | M | 10 | −3.42 | −3.03 | −0.98 | 10.2 | −1.62 | −3.26 | Advanced bone age (+1.9 years) | IHH | M/n | c.857C>T | p.Pro286Leu | No | Uncertain significance |
5 | M | 9 | −3.34 | −2.67 | −0.92 | NA | −2.13 | −3.52 | — | COL9A2 | M/n | c.1834G>A | p.Gly612Arg | Yes | Benign |
6 | M | 16 | −3.06 | −2.75 | 0.16 | 19.3 | −2.39 | −2.57 | Scoliosis | COL11A1 | M/n | c.1543C>G | p.Gln515Glu | Yes | Likely pathogenic |
7 | M | 10 | −2.92 | −3.30 | −0.63 | 29.7 | −1.35 | −2.13 | — | IGF1R | M/n | c.158C>T | p.Thr53Met | Yes | Likely pathogenic |
8 | F | 11 | −2.76 | −2.75 | −1.04 | NA | −2.56 | −4.14 | Frequent OMA, genua valga, advanced bone age (+3.4 y) | COL2A1 | M1/M2 | c.410G>A / c.3106C>G | p.Arg137His/ p.Arg1036Gly | Yes | Likely pathogenic (6) / Likely pathogenic |
GHD only – 4/9 (44.4%) with P/LP variant | |||||||||||||||
9 | M | 14 | −4.95 | −2.89 | −2.48 | 7.22 | −0.94 | −1.78 | Minor stigmata, bilateral cryptorchidism | IGFALS | M/n | c.860C>T | p.Pro287Leu | No | Uncertain significance (17) |
10 | M | 8 | −4.48 | −2.73 | −1.11 | 6.36 | −1.06 | −1.75 | B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulceration | MBTPS2 | M/- | c.1538T>C | p.Leu513Pro | Yes | Likely pathogenic (19) |
PIK3CD | M/n | c.1775T>C | p.Val952Ala | Yes | Uncertain significance | ||||||||||
11 | M | 7 | −4.37 | −2.89 | −1.86 | 9.40 | −0.56 | −1.04 | Limb shortening | FGFR3 | M/n | c.1612A>G | p.Ile538Val | Yes | Likely pathogenic (18) |
12 | F | 8 | −3.50 | −2.60 | −1.57 | 2.50 | 0.04 | −0.95 | Limb shortening | HSPG2 | M/n | c.8044C>T | p.Arg2682Trp | Yes | Benign |
13 | M | 13 | −3.10 | −2.59 | −1.91 | 5.92 | −0.85 | −0.65 | — | PAX6 | M/n | c.13C>G c.392C>G | p.His5Asp p.Ala131Gly | Yes | Benign |
14 | M | 5 | −3.06 | −3.86 | −2.18 | 8.34 | −1.94 | −1.42 | — | HMGA2 | M/n | c.223C>T | p.Arg75Trp | Yes | Likely pathogenic |
15 | M | 9 | −3.04 | −2.75 | −1.82 | 6.06 | −1.57 | −1.68 | Minor stigmata | IGFALS | M/n | c.589C>T | p.Arg197Cys | Yes | Pathogenic |
IHH | M/n | c.1169G>A | p.Arg390His | Yes | Uncertain significance | ||||||||||
16 | M | 8 | −2.75 | −2.75 | −1.23 | 7.79 | −1.02 | −1.35 | — | IGFALS | M/n | c.1195G>A | p.Gly399Arg | No | Uncertain significance |
17 | M | 12 | −2.53 | −2.75 | −1.28 | 8.30 | −1.60 | −0.65 | — | GH1 | M/n | c.478C>T | p.Arg160Trp | Yes | Benign |
FBN1 | M/n | c.902G>T | p.Gly301Val | Yes | Benign | ||||||||||
SGA + GHD – 3/11 (27.3%) with P/LP variant | |||||||||||||||
18 | M | 9 | −4.17 | −3.81 | −1.98 | 5.18 | −1.95 | −3.09 | Hypospadia, minor stigmata | HSPG2 | M/n | c.12874G>A | p.Glu4292Lys | Yes | Benign |
19 | F | 8 | −3.82 | −4.03 | −0.44 | 7.77 | −0.84 | −2.14 | Limb shortening | GLI2 GLI2 | M/n | c.4332G>A c.4333C>T | p.Met1444Ile p.Leu1445Phe | Yes | Benign |
20 | M | 6 | −3.61 | −3.25 | −1.14 | 6.4 | −2.16 | −3.12 | — | — | — | — | — | — | No variant found |
21 | M | 14 | −3.47 | −2.89 | −1.63 | 8.39 | −2.39 | −3.00 | Microcephaly | COL2A1 | M/n | c.3106C>G | p.Arg1036Gly | Yes | Likely pathogenic |
22 | M | 8 | −3.28 | −2.89 | −1.83 | 6.37 | −0.60 | −2.39 | — | — | — | — | — | — | No variant found |
23 | M | 13 | −3.26 | −2.81 | −1.22 | 7.44 | −2.18 | −2.22 | — | SHH | M/n | c.424G>A | p.Glu142Lys | Yes | Benign |
24 | F | 14 | −3.18 | −2.75 | −2.1 | 7.15 | −2.56 | −3.13 | Lower-limb shortening, minor stigmata | GHSR | M/n | c.526G>A | p.Gly176Arg | Yes | Pathogenic |
25 | M | 8 | −2.84 | −2.87 | −0.98 | 5.91 | −2.59 | −2.83 | Minor stigmata | COL10A1 | M/n | c.1581G>C | p.Lys527Asn | Yes | Likely benign |
26 | F | 12 | −2.76 | −2.89 | −3.45 | 3.62 | −2.78 | −1.23 | Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitary | — | — | — | — | — | No variant found |
27 | M | 10 | −2.70 | −2.75 | −0.66 | 3.44 | −2.39 | −3.43 | — | EXT2 | M/n | c.2034G>C | p.Lys678Asn | No | Uncertain significance |
28 | M | 5 | −2.62 | −3.60 | −2.25 | 6.99 | −1.40 | −2.22 | — | FLNB | M/n | c.1601T>G | p.Ile534Ser | Yes | Likely pathogenic |
Patient No. . | Sex . | Age, y . | Patient`s Height (SDS) . | Shorter Parent`s Height (SDS) . | IGF-1 (SDS) . | Stimulated GH, μg/L . | Birth Weight (SDS) . | Birth Length (SDS) . | Additional Phenotypic Features . | Gene . | Mutation Status . | Transcript Variant . | Protein Variant . | Parents Available for Genetic Testing . | Conclusion . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SGA only – 5/8 (62.5%) with P/LP variant | |||||||||||||||
1 | F | 10 | −4.32 | −3.54 | −1.68 | 11.0 | −1.64 | −3.05 | — | COL11A1 | M/n | c.2921C>A | p.Pro974Gln | Yes | Likely pathogenic |
2 | M | 14 | −4.10 | −2.89 | −3.68 | 10.0 | −1.64 | −2.39 | Central hypothyroidism | TRHR | M/M | c.392T>C | p.Ile131Thr | Yes | Likely pathogenic (16) |
3 | M | 12 | −3.49 | −3.00 | −0.26 | 11.5 | −3.01 | −3.87 | — | THRA | M/n | c.455G>A | p.Arg152Gln | Yes | Uncertain significance |
4 | M | 10 | −3.42 | −3.03 | −0.98 | 10.2 | −1.62 | −3.26 | Advanced bone age (+1.9 years) | IHH | M/n | c.857C>T | p.Pro286Leu | No | Uncertain significance |
5 | M | 9 | −3.34 | −2.67 | −0.92 | NA | −2.13 | −3.52 | — | COL9A2 | M/n | c.1834G>A | p.Gly612Arg | Yes | Benign |
6 | M | 16 | −3.06 | −2.75 | 0.16 | 19.3 | −2.39 | −2.57 | Scoliosis | COL11A1 | M/n | c.1543C>G | p.Gln515Glu | Yes | Likely pathogenic |
7 | M | 10 | −2.92 | −3.30 | −0.63 | 29.7 | −1.35 | −2.13 | — | IGF1R | M/n | c.158C>T | p.Thr53Met | Yes | Likely pathogenic |
8 | F | 11 | −2.76 | −2.75 | −1.04 | NA | −2.56 | −4.14 | Frequent OMA, genua valga, advanced bone age (+3.4 y) | COL2A1 | M1/M2 | c.410G>A / c.3106C>G | p.Arg137His/ p.Arg1036Gly | Yes | Likely pathogenic (6) / Likely pathogenic |
GHD only – 4/9 (44.4%) with P/LP variant | |||||||||||||||
9 | M | 14 | −4.95 | −2.89 | −2.48 | 7.22 | −0.94 | −1.78 | Minor stigmata, bilateral cryptorchidism | IGFALS | M/n | c.860C>T | p.Pro287Leu | No | Uncertain significance (17) |
10 | M | 8 | −4.48 | −2.73 | −1.11 | 6.36 | −1.06 | −1.75 | B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulceration | MBTPS2 | M/- | c.1538T>C | p.Leu513Pro | Yes | Likely pathogenic (19) |
PIK3CD | M/n | c.1775T>C | p.Val952Ala | Yes | Uncertain significance | ||||||||||
11 | M | 7 | −4.37 | −2.89 | −1.86 | 9.40 | −0.56 | −1.04 | Limb shortening | FGFR3 | M/n | c.1612A>G | p.Ile538Val | Yes | Likely pathogenic (18) |
12 | F | 8 | −3.50 | −2.60 | −1.57 | 2.50 | 0.04 | −0.95 | Limb shortening | HSPG2 | M/n | c.8044C>T | p.Arg2682Trp | Yes | Benign |
13 | M | 13 | −3.10 | −2.59 | −1.91 | 5.92 | −0.85 | −0.65 | — | PAX6 | M/n | c.13C>G c.392C>G | p.His5Asp p.Ala131Gly | Yes | Benign |
14 | M | 5 | −3.06 | −3.86 | −2.18 | 8.34 | −1.94 | −1.42 | — | HMGA2 | M/n | c.223C>T | p.Arg75Trp | Yes | Likely pathogenic |
15 | M | 9 | −3.04 | −2.75 | −1.82 | 6.06 | −1.57 | −1.68 | Minor stigmata | IGFALS | M/n | c.589C>T | p.Arg197Cys | Yes | Pathogenic |
IHH | M/n | c.1169G>A | p.Arg390His | Yes | Uncertain significance | ||||||||||
16 | M | 8 | −2.75 | −2.75 | −1.23 | 7.79 | −1.02 | −1.35 | — | IGFALS | M/n | c.1195G>A | p.Gly399Arg | No | Uncertain significance |
17 | M | 12 | −2.53 | −2.75 | −1.28 | 8.30 | −1.60 | −0.65 | — | GH1 | M/n | c.478C>T | p.Arg160Trp | Yes | Benign |
FBN1 | M/n | c.902G>T | p.Gly301Val | Yes | Benign | ||||||||||
SGA + GHD – 3/11 (27.3%) with P/LP variant | |||||||||||||||
18 | M | 9 | −4.17 | −3.81 | −1.98 | 5.18 | −1.95 | −3.09 | Hypospadia, minor stigmata | HSPG2 | M/n | c.12874G>A | p.Glu4292Lys | Yes | Benign |
19 | F | 8 | −3.82 | −4.03 | −0.44 | 7.77 | −0.84 | −2.14 | Limb shortening | GLI2 GLI2 | M/n | c.4332G>A c.4333C>T | p.Met1444Ile p.Leu1445Phe | Yes | Benign |
20 | M | 6 | −3.61 | −3.25 | −1.14 | 6.4 | −2.16 | −3.12 | — | — | — | — | — | — | No variant found |
21 | M | 14 | −3.47 | −2.89 | −1.63 | 8.39 | −2.39 | −3.00 | Microcephaly | COL2A1 | M/n | c.3106C>G | p.Arg1036Gly | Yes | Likely pathogenic |
22 | M | 8 | −3.28 | −2.89 | −1.83 | 6.37 | −0.60 | −2.39 | — | — | — | — | — | — | No variant found |
23 | M | 13 | −3.26 | −2.81 | −1.22 | 7.44 | −2.18 | −2.22 | — | SHH | M/n | c.424G>A | p.Glu142Lys | Yes | Benign |
24 | F | 14 | −3.18 | −2.75 | −2.1 | 7.15 | −2.56 | −3.13 | Lower-limb shortening, minor stigmata | GHSR | M/n | c.526G>A | p.Gly176Arg | Yes | Pathogenic |
25 | M | 8 | −2.84 | −2.87 | −0.98 | 5.91 | −2.59 | −2.83 | Minor stigmata | COL10A1 | M/n | c.1581G>C | p.Lys527Asn | Yes | Likely benign |
26 | F | 12 | −2.76 | −2.89 | −3.45 | 3.62 | −2.78 | −1.23 | Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitary | — | — | — | — | — | No variant found |
27 | M | 10 | −2.70 | −2.75 | −0.66 | 3.44 | −2.39 | −3.43 | — | EXT2 | M/n | c.2034G>C | p.Lys678Asn | No | Uncertain significance |
28 | M | 5 | −2.62 | −3.60 | −2.25 | 6.99 | −1.40 | −2.22 | — | FLNB | M/n | c.1601T>G | p.Ile534Ser | Yes | Likely pathogenic |
Abbreviations: F, female; GHD, GH deficiency; LP, likely pathogenic; M, male; M/n, heterozygote; M/M, homozygote; M1/M2, compound heterozygote; M/-, hemizygote; OMA, otitis media acuta; P, pathogenic; SDS, SD score; SGA, small for gestational age.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.